Novartis AG, the drugmaker that plans to launch four major medicines, will open a US$100 million research center in Shanghai next year to attract Chinese talent to replenish its product pipeline.
The site, set to become the eighth in the company's research network, will be staffed by scientists recruited from Shanghai-based institutions, Novartis said yesterday.
The new facility will allow the company to benefit from the growing number of highly skilled Chinese scientists, chief executive officer Daniel Vasella said. That may give the Basel, Switzerland-based company an advantage in finding new products at a time when best-selling drugs are going off-patent and research costs soar.
"The most important aspect is that in Shanghai there is a pool of scientific talent emerging," Vasella said in a telephone interview on Sunday.
The site will also help Novartis build contacts to research institutions and doctors in a key market. Worldwide drug sales will rise 5 percent to 6 percent next year to as much as US$685 billion, according to a report last month by research firm IMS Health Inc. China will be one of the fastest-growing markets, increasing 15 percent to 16 percent to about US$16 billion next year.
In China about 85 percent of people pay for drugs themselves, so makers aren't pressured by insurers or the government to lower prices as much as in other parts of the world.
Swiss rival Roche Holding AG runs two factories and one research facility in China. Roche said China revenue is estimated to reach 400 million Swiss francs (US$319 million) this year, driven by sales of the drugs.
In May, AstraZeneca Plc, the UK's second-largest drugmaker, said it would spend US$100 million in the next three years on research in China.
Novartis plans to introduce new treatments for diabetes, cancer and two for hypertension. Analysts expect the products each to bring sales of more than US$1 billion a year. The shares have outpaced larger rivals GlaxoSmithKline Plc and Sanofi-Aventis SA because of growth in heart drug Diovan and tumor-busting Gleevec.
Scientists at the Novartis center will study diseases including cancers caused by infections. Experts estimate hepatitis-induced liver cancer causes the death of 300,000 people in China each year.
The institute will open a smaller facility in May next year, the company said, before starting work on laboratories for 400 scientists.
The center will be headed by En Li, a native of Shanghai who now works at Novartis' Boston research site. The institute will also draw native Chinese returning from abroad, Fishman said.
It may take three years before the performance of the research can be reviewed, and about 12 to 15 years for it to develop new medicines, Vasella said. A similar research institute in India is "unlikely," Vasella said.
Novartis' predecessor Ciba opened its first office in Shanghai in 1938 to sell dyes, and the company is the fourth-largest supplier to Chinese hospitals. Novartis collaborates with the Shanghai Institute of Materia Medica to test traditional medicines, among other partnerships.
‘HERO OF THE ERA’: President Tsai Ing-wen expressed deep sadness at Lee’s passing, and told the government to assist his family with all their needs Former president Lee Teng-hui (李登輝) passed away at 7:24pm yesterday at Taipei Veterans General Hospital. He was 97 years old. The hospital stated the cause of death as septic shock and multiple organ failure. Lee had been hospitalized there since February, when he choked on a mouthful of milk at home. He was later diagnosed with pulmonary infiltrates and aspiration pneumonia. The hospital said that Lee had been treated with antibiotics, but that his health had not improved, as his advanced age and diabetes had inhibited his immune system and led to recurring infections. During his hospitalization, Lee underwent daily kidney dialysis, which removed
‘WEAK POSITIVE’: The man arrived in Taiwan in May and was quarantined for two weeks, Chen Shih-chung said, adding that he might be infected a long time ago The government is considering tightening mask-wearing rules again in light of a potential domestic COVID-19 infection, Minister of Health and Welfare Chen Shih-chung (陳時中) said yesterday. The Central Epidemic Command Center (CECC) confirmed seven new COVID-19 cases, six of which are imported. The other case involves a Belgian engineer who entered Taiwan on May 3 and remained in quarantine until May 17, said Chen, who heads the CECC. Although the source of infection has yet to be identified, the case could end the nation’s record of not having any domestic cases in the previous 110 days. The Belgian, in his 20s, is a technician
RECEIVING TREATMENT: President Tsai Ing-wen, Vice President William Lai and Premier Su Tseng-chang visited former president Lee Teng-hui yesterday morning Taipei Veterans General Hospital yesterday rebutted speculation that former president Lee Teng-hui (李登輝) had died a day earlier, saying that he was weak, but receiving treatment. The hospital said the 97-year-old Lee was not in good condition and needed ongoing care, adding that if there are any changes in his condition, it would make those public. The comments came after rumors emerged online on Tuesday that Lee had died after being hospitalized since early February. Soon after the unsubstantiated rumors emerged, reporters started flocking to the hospital seeking confirmation. Lee was admitted to Taipei Veterans General Hospital on Feb. 8 after choking while drinking
THAI CASE UPDATE: Twenty-nine close contacts of the worker have been tested with two types of tests, including 18 dorm mates, with 28 negative results so far Five imported cases of COVID-19, four from the Philippines and one from Hong Kong, were reported yesterday, bringing the total confirmed cases in Taiwan to 467, the Central Epidemic Command Center (CECC) said yesterday. The four returning from the Philippines were on the same flight, and the local health department has identified 15 people who had direct contact with them — including 10 passengers in the two rows in front or behind them, who have been put under 14-day home isolation, and five crew members, who will practice 14-day self-health management, said Centers for Disease Control (CDC) Deputy Director-General Chuang Jen-hsiang